Methicillin-resistant Staphylococcus aureus (MRSA) is one of the leading nosocomial
pathogen that is also emerging as a zoonotic pathogen. In this review, it was observed that rapid
emergence of new MRSA clones at a higher frequency has ushered in a new knowledge on the clonality
and epidemic potentials of MRSA. Secondly, the success of treatment and management of MRSA
infection is threatened by the diversity in the clonal types. This is because different clones harbours
different antibiotics resistance characteristics and as such respond differently to treatment. Furthermore,
clonal replacement of hospital-acquired MRSA with community -acquired MRSA has also been
observed. Thirdly, the transmission of MRSA even though previously thought to be exclusively within
the hospital setting through hand contact and nasal colonization has now spread to the community and in
addition human to animal and animal to human transmission has also been observed. Similarly, pet
owners, veterinarians and farmers have been described as high-risked group with potentials of becoming
reservoirs of MRSA. Furthermore, the adoption of hand hygiene in healthcare setting have to a great
extent reduced the incidence of MRSA in the hospital. And lastly, the advent of molecular typing such as
Pulsed Field Gel Electrophoresis (PFGE), Multi Locus Sequence Typing (MLST), Staphylococcal protein
A typing (Spa typing) and Double Locus Sequence Typing (DLST) have proven to be a useful tool in
providing valuable information on the evolution and clonal diversity of MRSA. These in turn help
researchers to answer some pertinent questions on the epidemiology of MRSA.